RespireRx Pharmaceuticals Inc (RSPI)

[enemem]

There's just no way this is a data analysis bottleneck.

If the only thing delaying announcement of the SA outcome is their own difficulty in analyzing the data, corx would throw what little they have left onto the fire to get this done. Corx has very little money, and even less time.

SoCal is chock-ablock with competent biomedical statisticians, so even if they couldn't think their way through the analysis, there are plenty of people who could in their neck of the woods.

Something else is up. Either they came very close to getting a good result, but some of the data were contaminated, or they are closing in on some kind of deal (this would also explain the lack of IND), or they have just flat-out lost it.